Innovative Minimally Invasive Circulatory Assist Device

The iVAC 3L

• Minimally invasive circulatory assist device, provides short term solution as a bridge to decision or as a bridge to bridge (LVAD).

• 3 l/m circulatory support in severe left ventricular failure

and during high-risk revascularisation procedures.

The Technology

Flexible thin-walled catheter containing a combined two way valve connected to a single port membrane pump

How it works

• During aspiration, blood enters the catheter through its tip located at the left ventricular and is aspirated into the membrane pump.

• The membrane pump pushes the blood back in the catheter, the valve at the side hole opens, and ejects the blood out sideways to aorta.

The iVAC 3L Placement

The tip of the catheter is located in the left ventricle and the catheter’s valve in the aorta.

How it works

Indications Patients with Heart Failure due to left

ventricular low output

•AMI (Heart Attack).•Cardiogenic Shock.•Post cardiotomy patients.•OPCAB (Off Pump Coronary Artery Bypass) - as recovery support.•PCI (Percutaneous Cardiac intervention).

Clinical Advantages

• Pulsatile support, pumping synchronized with the heart.• Increases circulatory blood flow.• Safe, reliable and easy to use platform technology.• Fast, subclavian or axillary artery percutaneous insertion.• Unloading of the left ventricle.• Increase of coronary and end-organ perfusion.• Low anticoagulation required; Anti Clotting time - 200 sec.• Reduction in myocardial workload.• Low complication rate.• Reduces risk of hemodynamic deterioration during High Risk interventions.

Technology Advantages • Common insertion technique.• One lumen 21 Fr. Catheter (6.9mm).• Short straightforward insertion. • Up to 3 L/min blood flow.• ECG triggered counter pulsation.• Driven by standard available IABP consoles.

Thank you